位置：成果数据库 > 期刊 > 期刊详情页
Emerging Roles of Dipeptidyl Peptidase 4 Inhibitors: Anti-Inflammatory and Immunomodulatory Effect a
  • 期刊名称：Canandian Journal of Diabetes
  • 时间：2014.12
  • 页码：473-479
  • 相关项目：谷氨酸脱羧酶疫苗诱导胰岛免疫耐受的机制研究
作者： Yang L|Yuan J|Zhou Z|
同期刊论文项目
谷氨酸脱羧酶疫苗诱导胰岛免疫耐受的机制研究
期刊论文 14 会议论文 2
同项目期刊论文
Exendin-4 Protects Mitochondria from Reactive Oxygen Species Induced Apoptosis in Pancreatic Beta Ce
Circulating lipocalin-2 and retinol-binding protein 4 are associated with intima-media thickness and
Therapeutic potential of umbilical cord blood cells for type 1 diabetes mellitus.
The new insights of DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabe
Biologic therapies in type 1 diabetes: how far are they from us?
Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Maintains beta-Cell Function in Patients With Recent-On
Dipeptidyl peptidase-4 inhibitors: multitarget drugs, not only antidiabetes drugs
DNA methylation impairs TLR9 induced Foxp3 expression by attenuating IRF-7 binding activity in fulmi
miR-101a and miR-30b contribute to inflammatory cytokine-mediated β-cell dysfunction.(2014 IF 3.676)
主要组织相容性复合体I类链相关基因A基因型在1型糖尿病及其亚型中的分布特点
miRNAs： novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes
1型糖尿病免疫治疗研究进展